US BANCORP \DE\ - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2022$16,000
+1500.0%
7,652
+2442.2%
0.00%
Q1 2022$1,000
-97.3%
301
-95.8%
0.00%
Q4 2021$37,000
+23.3%
7,173
+61.1%
0.00%
Q3 2021$30,000
+172.7%
4,452
+182.3%
0.00%
Q2 2021$11,000
+175.0%
1,577
+135.7%
0.00%
Q1 2021$4,000
-20.0%
669
+24.1%
0.00%
Q4 2020$5,000
-54.5%
539
-44.4%
0.00%
Q3 2020$11,000
+37.5%
970
+108.6%
0.00%
Q2 2020$8,000
-20.0%
465
-70.4%
0.00%
Q1 2020$10,000
+233.3%
1,570
+548.8%
0.00%
Q4 2019$3,0002420.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders